Well, not quite, my man. My Stop-Loss for Hemispherx BioPharma (AMEX:HEB) was triggered today when it reached $1.19. I sold 1,800 shares today leaving me with 500 share left stuck with the hope of FDA approval of Ampligen. I originally had 3,000 when this whole thing started back in May.
Based on yesterday's news it doesn't appear to me that there will be approval this year. And I think we all have less reason to trust Hemispherx Biopharma. Since May 25th we were under the impression that we were simply waiting to hear the FDA's verdict. But now it seems that the Ampligen application to the FDA wasn't complete.
I think we can expect to see HEB fall under a dollar. Ampligen may yet still get approved someday, my man. Just not this year.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment